Portfolio simulation may be an effective tool to forecast achievability of COVID-19 portfolio strategic goals, including risk mitigation to boost vaccines development and production.
Vladimir Shnaydman, PhD
Advertisement
Articles by Vladimir Shnaydman, PhD
Applied Clinical Trials
Policymakers should break with drug and biotech norms and apply risk-based portfolio simulations to understand the global portfolio of COVID-19 vaccines.
Applied Clinical Trials
Optimization model evaluates the benefits of selecting a portfolio of investigative sites based on advanced analytical models.
Applied Clinical Trials
Site selection is one of the most important and at the same time challenging problems in clinical trials planning. Poor site selection may cause enrollment delays, resource waste on low or zero enrollment, and even potentially compromise trial results.
Advertisement
Latest Updated Articles
Portfolio Approach to Optimize Site SelectionFebruary 5th 2019
Portfolio Approach to Optimize Site SelectionMarch 1st 2019
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When There’s No Registry: Building Rare Disease Evidence That Supports Regulatory Scrutiny
2
Sponsor Oversight in an Outsourced Trial: What Good Looks Like and How to Evidence It
3
How AI Is Changing Endpoint Selection Before a Trial Even Starts
4
How to recruit specialty volunteer populations for early-phase clinical research: 5 things to ask when choosing a CRO partner
5